Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Hyperway Pharm IS A Pharmaceutical research and development production enterprise
Pelage Pharma is a regenerative medicine biotechnology company developing treatments for hair loss.
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
CytoNiche is a 3D bionic cell technology company.
Navrogen is a biopharmaceutical company that focuses on the targeted treatment of cancer.
Zhongguancun Shuimu Medical Technology is a third-party medical device inspection and testing institution.
Rapafusyn Pharmaceuticals licenses technology related to a novel class of natural product-like macrocycle.
Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.
Libo Biotech is a company focused on developing innovative small molecule drugs targeting RNA.
Excalipoint Therapeutics is a Private limited company.
Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.
Xijian Technology is committed to advancing the industrialization of innovative human biomechanics imaging technology.
Cantai Therapeutics operates as a developer of drug candidates.
CryOSA is a medical device company developing novel treatments for obstructive sleep apnea.
Shuwen Biotech is engaged in licensing and developing innovative diagnostic products and services for disease prevention.
Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience.
Infinity Bio is a biotech company that offers analytics and insight services for antibody reactome profiling against all human viruses.
Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.
Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.
UltraClear is a skincare clinic that provides facial rejuvenation solutions for the treatment of all skin types.
Dermaliq's mission is to develop and sell the next generation of dermatology treatments for patients with severe unmet medical needs.
Junhemeng is a research and development company of recombinant protein drugs.
BioVenture has invested in 279 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioVenture's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics. The firm invests across 21 different industry categories.
Among tracked funding rounds, Pelage Pharmaceuticals received $120.0M in a Series B round. BioVenture's total known invested capital is $2.1B.
BioVenture's average investment size is $23.9M across its portfolio of 279 companies.
Recent BioVenture portfolio additions include Hyperway Pharm, Pelage Pharmaceuticals, AeroRx Therapeutics, OncoC4, AusperBio. These companies were founded in 2020 or later.